You are here

Article Text

Article menu
Download PDFPDF
Scientific letters
Impact of glycaemic and lipid control on outcome after percutaneous coronary interventions in diabetic patients
  1. C Briguori1,*,
  2. G Condorelli3,
  3. F Airoldi2,
  4. G W Mikhail2,
  5. B Ricciardelli1,
  6. A Colombo2
  1. 1Laboratory of Interventional Cardiology, Clinica Mediterranea, Naples, Italy
  2. 2San Raffaele Hospital, Milan, Italy
  3. 3Department of Biology, Cellular and Molecular Pathology, “Federico II” University, Naples, Italy
  1. Correspondence to:
    Dr Carlo Briguori
    Interventional Cardiology, Clinica Mediterranea, Via Orazio 2, I-80121, Naples, Italy; briguori.carlohsr.it

https://doi.org/10.1136/hrt.2003.030437

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Patients with type 2 diabetes mellitus account for approximately 20% of patients undergoing percutaneous coronary interventions (PCI). PCI is less effective in diabetic than in non-diabetic patients.1,2 Glycaemic and lipid control may have an impact on the clinical outcome in type 2 diabetic patients following elective PCI.

    METHODS

    From January 2000 to June 2001, 280 consecutive patients with type 2 diabetes mellitus successfully underwent their first elective PCI at one of our institutions. Optimal metabolic control was defined as a glycosylated haemoglobin (HbA1c) concentration of < 7.0% and a low density lipoprotein cholesterol (LDL-C) concentration < 100 mg/d (< 2.6 mmol/l). Three groups were identified: (1) …

    View Full Text

    Footnotes

    • ↵* Also at San Raffaele Hospital, Milan, Italy